ArticleBreast cancer research and treatment2022

Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions.

Claire E P Smith et al.PubMed ↗Publisher ↗

No numbers read from the abstract.